Aprogen Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aprogen Pharmaceuticals Inc with three other
companies in this sector in South Korea:
Seoul Pharma Co., Ltd.
sales of 44.14 billion Korean Won [US$36.42 million]
of which 100%
Jin Yang Pharmaceuticals Co Ltd
(46.86 billion Korean Won [US$38.66 million]
Samsung Pharmaceutical Co Ltd
(46.48 billion Korean Won [US$38.35 million]
of which 92%
was Pharmaceuticals Segment).
During the year ended December of 2018, sales at
Aprogen Pharmaceuticals Inc were 45.40 billion Korean Won (US$37.45 million).
decrease of 1.5%
versus 2017, when the company's sales were 46.10 billion Korean Won.